DOCSLIB.ORG

Severe Infectious Diseases of Childhood As Monogenic Inborn Errors of Immunity

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Severe Infectious Diseases of Childhood As Monogenic Inborn Errors of Immunity Severe infectious diseases of childhood as monogenic PNAS PLUS inborn errors of immunity Jean-Laurent Casanovaa,b,c,d,e,1 aSt. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY 10065; bHoward Hughes Medical Institute, New York, NY 10065; cLaboratory of Human Genetics of Infectious Diseases, Necker Branch, Inserm U1163, Necker Hospital for Sick Children, 75015 Paris, France; dImagine Institute, Paris Descartes University, 75015 Paris, France; and ePediatric Hematology and Immunology Unit, Assistance Publique–Hôpitaux de Paris, Necker Hospital for Sick Children, 75015 Paris, France Contributed by Jean-Laurent Casanova, November 3, 2015 (sent for review September 15, 2015; reviewed by Max D. Cooper and Richard A. Gatti) This paper reviews the developments that have occurred in the normally in other cells. P. vivax infections are rarely lethal today, field of human genetics of infectious diseases from the second half but the selective pressure exerted by this parasite may have fa- of the 20th century onward. In particular, it stresses and explains vored the spread of this allele, which is more common in infested the importance of the recently described monogenic inborn errors areas and is fixed in some African populations. These findings do of immunity underlying resistance or susceptibility to specific infec- not explain the pathogenesis of P. vivax malaria, but they do tions. The monogenic component of the genetic theory provides a explain why some individuals are not infected despite repeated plausible explanation for the occurrence of severe infectious diseases exposure to the parasite. They also show that a pathogen can during primary infection. Over the last 20 y, increasing numbers of favor the spread of a human allele conferring Mendelian pro- life-threatening infectious diseases striking otherwise healthy chil- tection against the pathogen concerned. dren, adolescents, and even young adults have been attributed to single-gene inborn errors of immunity. These studies were inspired Other Forms of Mendelian Resistance to Infection by seminal but neglected findings in plant and animal infections. Another set of similar studies in 1996 explained why the HIV did Infectious diseases typically manifest as sporadic traits because not infect rare individuals in vivo, despite repeated exposure human genotypes often display incomplete penetrance (most genet- + through sexual contact. The CD4 T cells of these individuals GENETICS ically predisposed individuals remain healthy) and variable expressiv- were shown to be resistant to infection in vitro. An autosomal ity (different infections can be allelic at the same locus). Infectious recessive chemokine (C-C motif) receptor 5 (CCR5) deficiency diseases of childhood, once thought to be archetypal environmental was rapidly identified in these subjects (5–7). The most com- diseases, actually may be among the most genetically determined mon mutation underlying this phenotype probably originated in conditions of mankind. This nascent and testable notion has in- Scandinavia, and the evolutionary forces driving its spread to- teresting medical and biological implications. ward Southern Europe have remained elusive. The third and last case we will consider here is autosomal recessive fucosyl- human genetics | immunology | infectious diseases | pediatrics | transferase 2 (FUT2) deficiency, which was discovered in 2003. primary immunodeficiency Individuals with this deficiency are naturally resistant to diarrhea caused by noroviruses (8, 9). This condition is typically benign in his paper reviews the monogenic inborn errors of immunity the developed world today but would have been potentially life- Tthat have been shown to underlie resistance or vulnerability threatening in ancient times, as it still is in developing countries. to human infectious diseases. These studies, first conducted in With these three examples, we have true genetic determinism the 1970s, gained momentum from the mid-1990s onward. The that is autosomal recessive with complete or almost complete analysis of Mendelian traits was followed by that of non- penetrance. The monogenic lesions prevent infection through a Mendelian monogenic traits, characterized by incomplete clini- cal penetrance and variable expressivity. causal mechanism (i.e., lack of cell infection by a specific microbe). Significance Mendelian Resistance to Malaria An example of infection shaping the human genome was pro- The key problem concerning pediatric infectious diseases, and vided by the discovery of Mendelian resistance to Plasmodium vivax more generally clinical diseases during primary infection, is (1, 2). It is important to stress here that these studies their pathogenesis. A plausible and testable human genetic concerned infection per se and not its manifestations (Table 1). theory of primary infectious diseases has recently emerged, As discussed in the companion paper (3), only a minority of building on elegant studies in plants and animals. Three ex- infected individuals develop clinical disease, and an even smaller amples of monogenic resistance to common infections have minority develop life-threatening disease in the course of pri- been discovered. Moreover, a growing range of monogenic mary infection. Moreover, not all exposed individuals become single-gene inborn errors of immunity, rarely Mendelian (with infected. In at least three cases, this phenomenon has been complete clinical penetrance) but more commonly non- shown to be a Mendelian phenotype because of a well-defined Mendelian (with incomplete penetrance), have been found to monogenic genotype for a microbial receptor or coreceptor. underlie severe infectious diseases striking otherwise healthy Louis Miller carried out pioneering studies in this area. In 1976, children during primary infection. These findings provide a he discovered that an autosomal recessive deficiency of the Duffy synthetic framework for inherited and infectious diseases and, antigen and receptor for chemokines (DARC) in erythrocytes more generally, for inborn and environmental conditions. prevented the infection of these cells with Plasmodium vivax in vitro and the infection of individuals in vivo (1). An elegant set of Author contributions: J.-L.C. designed research, performed research, analyzed data, and follow-up studies demonstrated that this resistance could be at- wrote the paper. tributed to a single nucleotide mutation in the DARC promoter, Reviewers: M.D.C., Emory University; and R.A.G., University of California, Los Angeles. preventing the binding of the transcription factor GATA-binding The authors declare no conflict of interest. protein 1 (GATA1), which is required for DARC expression in Freely available online through the PNAS open access option. the erythrocyte lineage (4). Affected individuals express DARC 1Email: [email protected]. www.pnas.org/cgi/doi/10.1073/pnas.1521651112 PNAS Early Edition | 1of10 Downloaded by guest on September 26, 2021 Table 1. Mendelian resistance to human infection errors of IFN-γ immunity involving nine genes (19–23). Some γ Infection Gene Inheritance Year MSMD-causing genes control the production of IFN- ; others govern its action. These nine MSMD-causing genes display high P. vivax DARC Autosomal recessive 1975 levels of allelic heterogeneity. However, these deficiencies dis- HIV CCR5 Autosomal recessive 1996 play physiological homogeneity, because all defects impair IFN-γ Norovirus FUT2 Autosomal recessive 2003 immunity. Moreover, human IFN-γ immunity, as a quantitative trait, controls host defense against mycobacteria. The clinical The three phenotypes are autosomal recessive. Biallelic mutations underlie γ complete deficiency of any of these three microbial receptors or coreceptors. features of MSMD depend strongly on the levels of IFN- im- These deficiencies can be common, especially in areas where the correspond- munity, being most severe in patients with complete IFN-γ de- ing infection can select the resistance genotype. Clinical penetrance (resistance ficiency (24). The clinical implications of this work are obvious. to infection per se) is complete or almost complete. The infections and re- These studies identified the genetic defects underlying these sistance genes are described in the text, as are the references. Mendelian infections, providing molecular genetic proof that mycobacterial disease could be Mendelian. The patients are treated with IFN-γ and antibiotics or by hematopoietic stem cell These findings concern very large numbers of individuals and neatly transplantation when the receptor is completely nonfunctional. illustrate the potential impact of Mendelian genetics at the pop- The immunological implications are not negligible: These studies ulation level. These findings have important biological implications, confirmed Carl Nathan’s suggestion that IFN-γ is much more a because these three sets of studies demonstrate the essential nature macrophage-activating factor than an antiviral agent (25). They of a single specific gene for each infection. The clinical implications + also showed that the Th1 arm of CD4 T cells (IL-12 being the are equally important, because blocking these molecules in other γ individuals is a rational approach to prevention or therapy. It is Th1-inducing signature cytokine and IFN- the Th1 effector sig- surprising that this field has not blossomed. For almost all common nature cytokine), which in inbred mice had been reported
Load more

Recommended publications
  • The Genetics of Nontraditional Glycemic Biomarkers of Type 2 Diabetes
    THE GENETICS OF NONTRADITIONAL GLYCEMIC BIOMARKERS OF TYPE 2 DIABETES by Stephanie J. Loomis, MPH A dissertation submitted to The Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland May, 2018 © 2018 Stephanie J. Loomis All rights reserved Abstract Type 2 diabetes is a major public health problem that affects over 10% of the US adult population. It is associated with substantially increased risks of mortality and serious clinical outcomes such as heart disease, stroke, kidney disease and retinopathy. Diabetes is defined by hyperglycemia, or elevated glucose concentrations in the blood, which are commonly measured by fasting glucose and hemoglobin A1c (HbA1c), but these have limitations. As a result, nontraditional glycemic biomarkers, fructosamine, glycated albumin and 1,5-anhydroglucitol (1,5-AG) are gaining interest. While it is established that genetics play a role in type 2 diabetes, fasting glucose, and HbA1c, the genetics of fructosamine, glycated albumin, and 1,5-AG have not been well explored. This dissertation sought to determine the amount of variation in each biomarker due to genetics through heritability estimation, and to determine the specific genetic variants associated with each biomarker though genome wide association study (GWAS) analysis, multivariate phenotype analysis, and exome sequencing analysis. Heritability estimates showed a substantial portion of fructosamine, glycated albumin and 1,5-AG variation was due to genetics, which is likely comprised of both common and rare variants. GWAS identified common variants associated with fructosamine and glycated albumin including a known diabetes variant and a likely nonglycemic variant. Exome sequencing did not identify variants associated with fructosamine and glycated albumin, but multivariate phenotype analysis identified a potentially interesting region in a gene that alters bilirubin levels that may affect fructosamine in a nonglycemic manner.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • SUPPLEMENTARY DATA Principal Investigators and Acknowledgment
    SUPPLEMENTARY DATA Principal Investigators and Acknowledgment Hispanic Community Health Study/Study of Latinos (HSHC/SOL) Robert Kaplan, Sylvia Wassertheil-Smoller (Bronx); Martha L. Daviglus, Aida L. Giachello (Chicago); Neil Schneiderman, David Lee, Leopoldo Raij, John Ryan (Miami); Greg Talavera, John Elder, Matthew Allison, Michael Criqui (San Deigo). The authors thank the staff and participants of HCHS/SOL for their important contributions. A complete list of staff and investigators has been provided by Sorlie P., et al. in Ann Epidemiol. 2010 ;20:642-649 and is also available on the study website http://www.cscc.unc.edu/hchs/. The baseline examination of the Hispanic Community Health Study/Study of Latinos was carried out as a collaborative study supported by contracts from the National Heart, Lung, and Blood Institute (NHLBI) to the University of North Carolina (N01-HC65233), University of Miami (N01-HC65234), Albert Einstein College of Medicine (N01-HC65235), Northwestern University (N01-HC65236), and San Diego State University (N01-HC65237). The following Institutes/Centers/Offices contributed to the HCHS/SOL first funding period through a transfer of funds to the NHLBI: National Institute on Minority Health and Health Disparities, the National Institute of Deafness and Other Communications Disorders, the National Institute of Dental and Craniofacial Research, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Neurological Disorders and Stroke, and the NIH Office of Dietary Supplements. The Genetic Analysis Center at the University of Washington was supported by NHLBI and NIDCR contracts (HHSN268201300005C AM03 and MOD03). Genotyping efforts were supported by NHLBI HSN 26220/20054C, NCATS CTSI grant UL1TR000123, and NIDDK Diabetes Research Center (DRC) grant DK063491.
    [Show full text]
  • (ESI) for Toxicology Research
    Electronic Supplementary Material (ESI) for Toxicology Research. This journal is © The Royal Society of Chemistry 2014 Supplementary data 1 Particle preparation and characterization 1.1 SWCNT preparation The purchased SWCNTs (P2-SWNTs, Carbon Solutions, Inc. CA, USA) have a poor dispersibility and colloidal stability in aqueous medium. To make well-dispersed SWCNTs in aqueous medium with a proper colloidal stability for the duration of the experiments, the purchased SWCNTs were accurately weighted and suspended in dimethyl sulfoxide (DMSO) to 0.125 mg/mL, followed by ultrasonication for 30 minutes in a water bath sonicator (B3510, Branson Ultrasonics, 40KHz). In the last minute of ultrasonication, the SWCNTs-DMSO suspension was rapidly diluted 5 times by injecting a stabilization buffer (5 mg/mL BSA and 10 mM NaCl in MilliQ water). The mixture, referred to as as-dispersed SWCNTs (AD-SWCNTs), resulted in a clear dark-brown suspension. No sedimentation of AD-SWCNTs was observed for weeks at room temperature indicating a good colloidal stability. To remove the majority of DMSO and free BSA, AD-SWCNTs were pelleted by centrifugation at 16,000 g, 4 °C for 30 min followed by three times wash with 10 mM NaCl in MilliQ water under the same conditions. The colloidal stability and surface charge of SWCNTs at each step were monitored by dynamic light scattering analysis (DLS) (see below). The depletion of DMSO and BSA was monitored by UV-Visible absorption analysis (see below). The SWCNTs aggregates and metallic impurities were characterized by TEM and TEM-EDX (see below). After the washing steps, SWCNTs were re-dispersed in MilliQ water with 10 mM NaCl to about 0.4 mg/mL, which was used in the experiments and here referred to as prepared SWCNTs.
    [Show full text]
  • Comprehensive Genetic Testing for Primary Immunodeficiency
     Woon and Ameratunga Allergy Asthma Clin Immunol (2016) 12:65 Allergy, Asthma & Clinical Immunology DOI 10.1186/s13223-016-0169-2 RESEARCH Open Access Comprehensive genetic testing for primary immunodeficiency disorders in a tertiary hospital: 10‑year experience in Auckland, New Zealand See‑Tarn Woon and Rohan Ameratunga* Abstract Background and purpose: New Zealand is a developed geographically isolated country in the South Pacific with a population of 4.4 million. Genetic diagnosis is the standard of care for most patients with primary immunodeficiency disorders (PIDs). Methods: Since 2005, we have offered a comprehensive genetic testing service for PIDs and other immune-related disorders with a published sequence. Here we present results for this program, over the first decade, between 2005 and 2014. Results: We undertook testing in 228 index cases and 32 carriers during this time. The three most common test requests were for X-linked lymphoproliferative (XLP), tumour necrosis factor receptor associated periodic syndrome (TRAPS) and haemophagocytic lymphohistiocytosis (HLH). Of the 32 suspected XLP cases, positive diagnoses were established in only 2 patients. In contrast, genetic defects in 8 of 11 patients with suspected X-linked agammaglobu‑ linemia (XLA) were confirmed. Most XLA patients were initially identified from absence of B cells. Overall, positive diagnoses were made in about 23% of all tests requested. The diagnostic rate was lowest for several conditions with locus heterogeneity. Conclusions: Thorough clinical characterisation of patients can assist in prioritising which genes should be tested. The clinician-driven customised comprehensive genetic service has worked effectively for New Zealand. Next genera‑ tion sequencing will play an increasing role in disorders with locus heterogeneity.
    [Show full text]
  • Are Complement Deficiencies Really Rare?
    G Model MIMM-4432; No. of Pages 8 ARTICLE IN PRESS Molecular Immunology xxx (2014) xxx–xxx Contents lists available at ScienceDirect Molecular Immunology j ournal homepage: www.elsevier.com/locate/molimm Review Are complement deficiencies really rare? Overview on prevalence, ଝ clinical importance and modern diagnostic approach a,∗ b Anete Sevciovic Grumach , Michael Kirschfink a Faculty of Medicine ABC, Santo Andre, SP, Brazil b Institute of Immunology, University of Heidelberg, Heidelberg, Germany a r a t b i c s t l e i n f o r a c t Article history: Complement deficiencies comprise between 1 and 10% of all primary immunodeficiencies (PIDs) accord- Received 29 May 2014 ing to national and supranational registries. They are still considered rare and even of less clinical Received in revised form 18 June 2014 importance. This not only reflects (as in all PIDs) a great lack of awareness among clinicians and gen- Accepted 23 June 2014 eral practitioners but is also due to the fact that only few centers worldwide provide a comprehensive Available online xxx laboratory complement analysis. To enable early identification, our aim is to present warning signs for complement deficiencies and recommendations for diagnostic approach. The genetic deficiency of any Keywords: early component of the classical pathway (C1q, C1r/s, C2, C4) is often associated with autoimmune dis- Complement deficiencies eases whereas individuals, deficient of properdin or of the terminal pathway components (C5 to C9), are Warning signs Prevalence highly susceptible to meningococcal disease. Deficiency of C1 Inhibitor (hereditary angioedema, HAE) Meningitis results in episodic angioedema, which in a considerable number of patients with identical symptoms Infections also occurs in factor XII mutations.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Identification of Potential Key Genes and Pathway Linked with Sporadic Creutzfeldt-Jakob Disease Based on Integrated Bioinformatics Analyses
    medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Identification of potential key genes and pathway linked with sporadic Creutzfeldt-Jakob disease based on integrated bioinformatics analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Abstract Sporadic Creutzfeldt-Jakob disease (sCJD) is neurodegenerative disease also called prion disease linked with poor prognosis. The aim of the current study was to illuminate the underlying molecular mechanisms of sCJD. The mRNA microarray dataset GSE124571 was downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were screened.
    [Show full text]
  • Practice Parameter for the Diagnosis and Management of Primary Immunodeficiency
    Practice parameter Practice parameter for the diagnosis and management of primary immunodeficiency Francisco A. Bonilla, MD, PhD, David A. Khan, MD, Zuhair K. Ballas, MD, Javier Chinen, MD, PhD, Michael M. Frank, MD, Joyce T. Hsu, MD, Michael Keller, MD, Lisa J. Kobrynski, MD, Hirsh D. Komarow, MD, Bruce Mazer, MD, Robert P. Nelson, Jr, MD, Jordan S. Orange, MD, PhD, John M. Routes, MD, William T. Shearer, MD, PhD, Ricardo U. Sorensen, MD, James W. Verbsky, MD, PhD, David I. Bernstein, MD, Joann Blessing-Moore, MD, David Lang, MD, Richard A. Nicklas, MD, John Oppenheimer, MD, Jay M. Portnoy, MD, Christopher R. Randolph, MD, Diane Schuller, MD, Sheldon L. Spector, MD, Stephen Tilles, MD, Dana Wallace, MD Chief Editor: Francisco A. Bonilla, MD, PhD Co-Editor: David A. Khan, MD Members of the Joint Task Force on Practice Parameters: David I. Bernstein, MD, Joann Blessing-Moore, MD, David Khan, MD, David Lang, MD, Richard A. Nicklas, MD, John Oppenheimer, MD, Jay M. Portnoy, MD, Christopher R. Randolph, MD, Diane Schuller, MD, Sheldon L. Spector, MD, Stephen Tilles, MD, Dana Wallace, MD Primary Immunodeficiency Workgroup: Chairman: Francisco A. Bonilla, MD, PhD Members: Zuhair K. Ballas, MD, Javier Chinen, MD, PhD, Michael M. Frank, MD, Joyce T. Hsu, MD, Michael Keller, MD, Lisa J. Kobrynski, MD, Hirsh D. Komarow, MD, Bruce Mazer, MD, Robert P. Nelson, Jr, MD, Jordan S. Orange, MD, PhD, John M. Routes, MD, William T. Shearer, MD, PhD, Ricardo U. Sorensen, MD, James W. Verbsky, MD, PhD GlaxoSmithKline, Merck, and Aerocrine; has received payment for lectures from Genentech/ These parameters were developed by the Joint Task Force on Practice Parameters, representing Novartis, GlaxoSmithKline, and Merck; and has received research support from Genentech/ the American Academy of Allergy, Asthma & Immunology; the American College of Novartis and Merck.
    [Show full text]
  • NIH Public Access Author Manuscript J Allergy Clin Immunol
    NIH Public Access Author Manuscript J Allergy Clin Immunol. Author manuscript; available in PMC 2008 December 12. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: J Allergy Clin Immunol. 2007 October ; 120(4): 776±794. doi:10.1016/j.jaci.2007.08.053. The International Union of Immunological Societies (IUIS) Primary Immunodeficiency Diseases (PID) Classification Committee Raif. S. Geha, M.D., Luigi. D. Notarangelo, M.D. [Co-chairs], Jean-Laurent Casanova, M.D., Helen Chapel, M.D., Mary Ellen Conley, M.D., Alain Fischer, M.D., Lennart Hammarström, M.D., Shigeaki Nonoyama, M.D., Hans D. Ochs, M.D., Jennifer Puck, M.D., Chaim Roifman, M.D., Reinhard Seger, M.D., and Josiah Wedgwood, M.D. Abstract Primary immune deficiency diseases (PID) comprise a genetically heterogeneous group of disorders that affect distinct components of the innate and adaptive immune system, such as neutrophils, macrophages, dendritic cells, complement proteins, NK cells, as well as T and B lymphocytes. The study of these diseases has provided essential insights into the functioning of the immune system. Over 120 distinct genes have been identified, whose abnormalities account for more than 150 different forms of PID. The complexity of the genetic, immunological, and clinical features of PID has prompted the need for their classification, with the ultimate goal of facilitating diagnosis and treatment. To serve this goal, an international Committee of experts has met every two years since 1970. In its last meeting in Jackson Hole, Wyoming, United States, following three days of intense scientific presentations and discussions, the Committee has updated the classification of PID as reported in this article.
    [Show full text]
  • A Curated Gene List for Reporting Results of Newborn Genomic Sequencing
    © American College of Medical Genetics and Genomics ORIGINAL RESEARCH ARTICLE A curated gene list for reporting results of newborn genomic sequencing Ozge Ceyhan-Birsoy, PhD1,2,3, Kalotina Machini, PhD1,2,3, Matthew S. Lebo, PhD1,2,3, Tim W. Yu, MD3,4,5, Pankaj B. Agrawal, MD, MMSC3,4,6, Richard B. Parad, MD, MPH3,7, Ingrid A. Holm, MD, MPH3,4, Amy McGuire, PhD8, Robert C. Green, MD, MPH3,9,10, Alan H. Beggs, PhD3,4, Heidi L. Rehm, PhD1,2,3,10; for the BabySeq Project Purpose: Genomic sequencing (GS) for newborns may enable detec- of newborn GS (nGS), and used our curated list for the first 15 new- tion of conditions for which early knowledge can improve health out- borns sequenced in this project. comes. One of the major challenges hindering its broader application Results: Here, we present our curated list for 1,514 gene–disease is the time it takes to assess the clinical relevance of detected variants associations. Overall, 954 genes met our criteria for return in nGS. and the genes they impact so that disease risk is reported appropri- This reference list eliminated manual assessment for 41% of rare vari- ately. ants identified in 15 newborns. Methods: To facilitate rapid interpretation of GS results in new- Conclusion: Our list provides a resource that can assist in guiding borns, we curated a catalog of genes with putative pediatric relevance the interpretive scope of clinical GS for newborns and potentially for their validity based on the ClinGen clinical validity classification other populations. framework criteria, age of onset, penetrance, and mode of inheri- tance through systematic evaluation of published evidence.
    [Show full text]
  • Novel TMC8 Splice Site Mutation in Epidermodysplasia Verruciformis and Review of HPV Infections in Patients with the Disease
    Novel TMC8 splice site mutation in epidermodysplasia verruciformis and review of HPV infections in patients with the disease E Imahorn1, Z Yüksel2, I Spoerri1, G Gürel3, C Imhof4, ZN Saraçoğlu5, AE Koku Aksu6, PL Rady7, SK Tyring7, W Kempf8, PH Itin1,9, B Burger1 1) Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland 2) Medical Genetics Department, Eskişehir Osmangazi University, Eskişehir, Turkey 3) Dermatology Department, Bozok University, Yozgat, Turkey 4) Stadtpraxis Brig, Brig, Switzerland 5) Dermatology Department, Eskişehir Osmangazi University, Eskişehir, Turkey 6) Dermatology Clinics, Istanbul Education and Research Hospital, Istanbul, Turkey 7) Department of Dermatology, McGovern Medical School at UTHealth, Houston, TX, USA 8) Kempf und Pfaltz Histologische Diagnostik, Zurich, Switzerland 9) Department of Dermatology, University Hospital Basel, Basel, Switzerland Contact: Bettina Burger Hebelstrasse 20 4031 Basel +41 61 328 69 03 [email protected] Funding sources: none Conflict of interest: none Keywords: Epidermodysplasia verruciformis, human papilloma virus, splice site mutation, TMC6, TMC8, genetic skin disease, genodermatosis Abstract Background: Epidermodysplasia verruciformis (EV) is a genodermatosis leading to infections with cutaneous HPV, persistent plane warts and a high rate of non-melanoma skin cancer (NMSC). Biallelic loss-of-function mutations in TMC6 and TMC8 are known to be causative. Objective: The aim of this study was to report EV-causing mutations in four patients with EV and to give an overview of all described EV patients. Patients and methods: We investigated four patients with classical features of EV from two families. All patients were affected by plane warts with typical EV histology since early childhood and β-HPVs were detected on their skin.
    [Show full text]